ABBV STOCK HITS RECORD ALL TIME HIGH

Great job by Rick and Schumacher in single-handedly generating support for hearings in the Judiciary Committee on Humira patents. I am no expert but appeared to be completely incompetent answers.

 

No I don’t trust Rick. I think he did very well though, but it’s all a dog and pony show. These politicians are all liars as is every person being questioned. Ken Frazier was kissing major political ass today. Only hard question was on executive compensation structure in relation to Humira price which was a no brainer and perfectly legal. They called out rick on Humira EU pricing and the $15B tax breaks. This was a big nothing burger today, with extra nothing. It’s all a charade and only the sheep think Pharma can be controlled by government. Not gonna happen.

 

I heard a brief mention about the academic papers being submitted but didn’t know who the question was directed at. Nothing about ricks travel expense. They only discussed Ricks 2017 comp because his 2018 comp was down 40%. Told y’all this was going to be a crock and a big fat YAWN.

 

Trumps a damn buffoon, when it comes to Corporate tax breaks. Should have NEVER gave the elite a license to steal MORE and buyback stock. The total stock buyback (using tax break) from all (7) of the Pharma company’s testifying today totaled $40B. Abbvie comprises $15B of it. SHAMEFUL!

 

Base salary of what? Base salary of Unprepared Rick? Public number.

 

Richard was the most informative and likable of all those testifying. Agree though is all a sham. Politicians are “partners in crime” with money hungry Coroprations.

 

Abbvie can’t keep paying dividends on stock. Watch them sink. The heavy debt load which is never talked about by Rick, could lead to bankruptcy. The negative return on equity for ABBV is a staggering -1,343.27%

 

The street has no faith in Abbvie being able to manage this insane debt level. RM and MS gave powder puff answers on Barclay conference call.

 

Yes they did dodge and deflect questions. No way can Abbvie continue to pay $1.07 dividends with heavy debt load.

 

So FDA placed a partial clinical hold on all clinical trials evaluating venetoclax? Looks like Phase 3 BELLINI trial was a disaster.

 

WARN issued and 178 gone in San Fran (sicko) to compensate for the failed stemcentrx acquisition. Good Riddance!

 

Long ball hitter, HQ wants to shut you down. They’re afraid of the data you have from Abbott pertaining to government contracts and pricing abuse. Is there Statutes of limitations and could legal proceedings be initiated?

 

The data I have covers many different areas. Some are active and others are past 7 statutes limit. I got no beef with Abbvie and don’t need the money, I have plenty. Also don’t need the aggravation and time consumption involved in litigation. The data on Abbott’s partnership with Perdue pushing Oxy is precious and pertains to current events. I sent EVERYTHING I had to DOJ last year.

 

Word is Abbvie is acquiring TG Therapeutics.

 

TGTX Good buy @ $8.12

 

ABBV Q418
Staggering figures and HEAVY DEBT LOAD

Net income -1.83B DOWN -3611.54%
Diluted EPS -1.22 DOWN -4166.67%
Net profit margin -21.99% DOWN -3382.09%

 

Weak close/sell off today. ER tomorrow should be Bottom line BEAT and Top line TANK!! EPS around $2.08.Y’all get ready for negative YoY revenue growth for Q1 of -1.7% down from 7.31% in Q418.

 

Q1 EPS of $2.14 Revenue for the quarter came in at $7.83 billion

 

Trumps corporate tax cuts for Q1 added $500M to Abbvie. Without it they wouldn’t have beat. Hopefully we’ll see $85 today, then a steady drop back to $78.